LOX-1 Regulation in Anti-atherosclerosis of Active Compounds of Herbal Medicine: Current Knowledge and the New Insight-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

LOX-1 Regulation in Anti-atherosclerosis of Active Compounds of Herbal Medicine: Current Knowledge and the New Insight

Published:2022-11-07 Issue:2 Volume:29 Page:179-185
ISSN:1672-0415
Container-title:Chinese Journal of Integrative Medicine
language:en
Short-container-title:Chin. J. Integr. Med.

Author:

Yao Si-jie,Lan Tao-hua,Zhang Xin-yu,Zeng Qiao-huang,Xu Wen-jing,Li Xiao-qing,Huang Gui-bao,Liu Tong,Lyu Wei-hui,Jiang Wei

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Complementary and alternative medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11655-022-3621-9.pdf

Reference52 articles.

1. Pothineni NVKM, Karathanasis SKP, Ding ZP, et al. LOX-1 in atherosclerosis and myocardial ischemia. J Am Coll Cardiol 2017;69:2759–2768.

2. Zeya B, Arjuman A, Chandra NC. Lectin-like oxidized low-density lipoprotein (LDL) receptor (LOX-1): a chameleon receptor for oxidized LDL. Biochemistry 2016;55:4437–4444.

3. Tian K, Ogura S, Little PJ, et al. Targeting LOX-1 in atherosclerosis and vasculopathy: current knowledge and future perspectives. Ann Ny Acad Sci 2019;1443:34–53.

4. Singh S, Gautam AS. Upregulated LOX-1 receptor: key player of the pathogenesis of atherosclerosis. Curr Atheroscler Rep 2019;21:38.

5. Chen M, Masaki T, Sawamura T. LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis. Pharmacol Ther (Oxford) 2002;95:89–100.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations of CKIP-1 and LOX-1 polymorphisms with the risk of type 2 diabetes mellitus with hypertension among Chinese adults;Acta Diabetologica;2023-09-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3